22.6 C
New York
Sunday, June 16, 2024

NuPathe Terminates Merger Agreement with Endo

Courtesy of Benzinga.

Endo Health Solutions (Nasdaq: ENDP) today announced that NuPathe (NASDAQ: PATH) has terminated its merger agreement with Endo.  Endo has received a $5 million termination fee from NuPathe.   

See full press release

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

157,087FansLike
396,312FollowersFollow
2,300SubscribersSubscribe

Latest Articles

0
Would love your thoughts, please comment.x
()
x